
    
      This study will be conducted in 2 steps with 2 study groups in each step. The entire study
      period for Step 1 is from Day -30 to Day 210 (240 days) The entire study period for Step 2 is
      from Day 0 to Day 180 for Group C and from Day 0 to Day 330 for Group D.

      Subjects will be blinded up to Day 60 in Step 1 and will be unblinded at the end of their Day
      60 visit. Step 2 will be conducted in an open-label manner.
    
  